Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

NC Büyükkaramikli; Saskia de Groot; D Fayter; R Wolff; N Armstrong; L Stirk; G Worthy; Fernando Albuquerque de Almeida; J Kleijnen; Maiwenn Al

doi:10.1007/s40273-017-0581-6

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

NC Büyükkaramikli, Saskia de Groot, D Fayter, R Wolff, N Armstrong, L Stirk, G Worthy, Fernando Albuquerque de Almeida, J Kleijnen, Maiwenn Al

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

3 Downloads (Pure)

Original language	English
Journal	Pharmacoeconomics (Print)
DOIs	https://doi.org/10.1007/s40273-017-0581-6
Publication status	Published - 31 Oct 2017

Access to Document

10.1007/s40273-017-0581-6

buyukkaramikli-et-al-2017-2.pdfFinal published version, 529 KB

http://hdl.handle.net/1765/105114

Cite this

Büyükkaramikli, NC., de Groot, S., Fayter, D., Wolff, R., Armstrong, N., Stirk, L., Worthy, G., Albuquerque de Almeida, F., Kleijnen, J., & Al, M. (2017). Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics (Print). https://doi.org/10.1007/s40273-017-0581-6

@article{b1cfac87a002450a8715e14bc88daabe,

title = "Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal",

author = "NC B{\"u}y{\"u}kkaramikli and {de Groot}, Saskia and D Fayter and R Wolff and N Armstrong and L Stirk and G Worthy and {Albuquerque de Almeida}, Fernando and J Kleijnen and Maiwenn Al",

year = "2017",

month = oct,

day = "31",

doi = "10.1007/s40273-017-0581-6",

language = "English",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis",

}

Büyükkaramikli, NC, de Groot, S, Fayter, D, Wolff, R, Armstrong, N, Stirk, L, Worthy, G, Albuquerque de Almeida, F, Kleijnen, J & Al, M 2017, 'Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal', Pharmacoeconomics (Print). https://doi.org/10.1007/s40273-017-0581-6

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. / Büyükkaramikli, NC; de Groot, Saskia; Fayter, D et al.

In: Pharmacoeconomics (Print), 31.10.2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

AU - Büyükkaramikli, NC

AU - de Groot, Saskia

AU - Fayter, D

AU - Wolff, R

AU - Armstrong, N

AU - Stirk, L

AU - Worthy, G

AU - Albuquerque de Almeida, Fernando

AU - Kleijnen, J

AU - Al, Maiwenn

PY - 2017/10/31

Y1 - 2017/10/31

U2 - 10.1007/s40273-017-0581-6

DO - 10.1007/s40273-017-0581-6

M3 - Article

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

ER -

Büyükkaramikli NC, de Groot S, Fayter D, Wolff R, Armstrong N, Stirk L et al. Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics (Print). 2017 Oct 31. https://doi.org/10.1007/s40273-017-0581-6